======= GPR116 ======= == Gene Information == * **Official Symbol**: ADGRF5 * **Official Name**: adhesion G protein-coupled receptor F5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221395|221395]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IZF2|Q8IZF2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GPR116&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GPR116|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620874|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor that plays a critical role in lung surfactant homeostasis. May play a role in controlling adipocyte function. {ECO:0000250|UniProtKB:G5E8Q8}. |GPS| |7tm 2| |SEA| |pharyngeal arch artery morphogenesis| |surfactant homeostasis| |glomerular filtration| |positive regulation of phospholipid biosynthetic process| |renal filtration| |chemical homeostasis within a tissue| |negative regulation of macrophage activation| |regulation of phospholipid biosynthetic process| |pharyngeal system development| |erythrocyte development| |positive regulation of phospholipid metabolic process| |regulation of macrophage activation| |myeloid cell development| |artery morphogenesis| |energy reserve metabolic process| |apical part of cell| |positive regulation of lipid biosynthetic process| |erythrocyte differentiation| |regulation of phospholipid metabolic process| |artery development| |erythrocyte homeostasis| |fat cell differentiation| |myeloid cell homeostasis| |renal system process| |positive regulation of lipid metabolic process| |negative regulation of leukocyte activation| |glucose homeostasis| |carbohydrate homeostasis| |regulation of lipid biosynthetic process| |tissue homeostasis| |negative regulation of cell activation| |homeostasis of number of cells| |myeloid cell differentiation| |energy derivation by oxidation of organic compounds| |cytoplasmic vesicle| |multicellular organismal homeostasis| |anatomical structure homeostasis| |regulation of lipid metabolic process| |blood vessel morphogenesis| |generation of precursor metabolites and energy| |negative regulation of immune system process| |blood vessel development| |vasculature development| |cardiovascular system development| |hemopoiesis| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |cell surface| |chordate embryonic development| |regulation of cell activation| |immune system development| |embryo development ending in birth or egg hatching| |tube morphogenesis| |G protein-coupled receptor activity| |tube development| |circulatory system development| |oxidation-reduction process| |embryo development| |chemical homeostasis| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |G protein-coupled receptor signaling pathway| |homeostatic process| |cell development| |regulation of immune system process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4572 * **Expression level (log2 read counts)**: -2.47 {{:chemogenomics:nalm6 dist.png?nolink |}}